Publication:
The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Citation

Candan O., Demirtas D., YANIK A. M., ATAGÜNDÜZ I., TOPTAŞ T., "The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia", Annals of Hematology, 2023

Endorsement

Review

Supplemented By

Referenced By